<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 30-year-old woman with <z:hpo ids='HP_0011009'>acute</z:hpo> promyelocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (APL) went into complete remission following <z:chebi fb="0" ids="42068">idarubicin</z:chebi> and <z:chebi fb="0" ids="28680">cytarabine</z:chebi> chemotherapy; 18 months later she developed repeated skin relapse, with no bone marrow involvement </plain></SENT>
<SENT sid="1" pm="."><plain>DNA and <z:chebi fb="40" ids="33697">RNA</z:chebi> analysis of <z:mp ids='MP_0001212'>skin lesions</z:mp> revealed the presence of the PML/RAR alpha hybrid gene, which was not detected at the same time in bone marrow </plain></SENT>
<SENT sid="2" pm="."><plain>The skin relapses were successfully treated by <z:hpo ids='HP_0000001'>all</z:hpo>-trans-<z:chebi fb="2" ids="26536">retinoic acid</z:chebi> (ATRA) as single agent over 2 years </plain></SENT>
<SENT sid="3" pm="."><plain>However, prolonged administration of ATRA caused <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumour cerebri</z:e>, which disappeared upon <z:e sem="disease" ids="C0152128" disease_type="Disease or Syndrome" abbrv="">drug withdrawal</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The absence of the hybrid gene in the bone marrow by RT-PCR analysis led to the patient being autografted </plain></SENT>
</text></document>